Mr. Kevin B. Young is Chief Operating Officer at Gilead Sciences, Inc.
He is on the Board of Directors at Interplast. Mr. Young was previously employed as a Principal by Amgen, Inc. and a Principal by AstraZeneca Pharmaceuticals LP.
He received his undergraduate degree from Liverpool John Moores University and a graduate degree from The University of Nottingham.